Negative Short-Term Outcome of Detoxification Therapy in Chronic Migraine With Medication Overuse Headache: Role for Early Life Traumatic Experiences and Recent Stressful Events

Sara Bottiroli, Federica Galli, Michele Viana, Roberto De Icco, Vito Bitetto, Marta Allena, Stefania Pazzi, Grazia Sances, Cristina Tassorelli, Sara Bottiroli, Federica Galli, Michele Viana, Roberto De Icco, Vito Bitetto, Marta Allena, Stefania Pazzi, Grazia Sances, Cristina Tassorelli

Abstract

Background: Early traumatic experiences and Stressful episodes appear to be associated to the development and perpetuation of chronic pain disorders and to dependence-related behaviors. Objective: The present study evaluated whether these factors can be predictors, together with psychiatric conditions, of the outcome of a detoxification treatment in patients suffering from chronic migraine and medication-overuse headache in a 2-month follow-up. Methods: Consecutive patients undergoing a detoxification program as therapy for treating chronic migraine and medication overuse headache at the Pavia Headache Center were analyzed. During this program, lasting about 1 week, all patients received the standard CARE in-patient withdrawal protocol, which consisted in discontinuing abruptly the overused drug(s) and receiving daily detoxification therapy. Data on childhood traumatic events and recent stressful ones were analyzed by means of the Childhood Trauma Questionnaire and Stressful life-events Questionnaire. Psychiatric conditions were evaluated using the Structured Clinical Interview for Diagnostic and Statistical Manual of mental disorders. Results: A total of 166 (80% females; mean age 44.7) patients completed the follow-up at 2 months after the detoxification program: of these 118 (71%) (78% females; mean age 44.7) stopped overuse and reverted to an episodic pattern of headache (Group A); 19 (11%) (89% females; mean age 41.3) kept overusing and maintained a chronic pattern of headache (Group B); and 29 (18%) (79% females; mean age 46.9) stopped overuse without any benefit on headache frequency (Group C). At the multivariate analyses, a higher number of early life emotional distress (Odds Ratio 11.096; p = 0.037) arose as a prognostic factor for the outcome in Group B, while major depression during life-time (Odds Ratio 3.703; p = 0.006) and higher number of severe stressful episodes in the past 10 years (Odds Ratio 1.679; p = 0.045) were prognostic factors for the outcome of Group C. Conclusions: Data suggest that early life traumas and stressful events have a negative impact on the outcome of the detoxification program in subjects overusing acute medication for headache. The history of emotional childhood traumas is associated to the failure to cease overuse, whereas recent very serious life events are associated to the persistence of headache chronicity.

Keywords: childhood traumas; follow-up; medication-overuse headache; psychological factors; stressful events.

Figures

Figure 1
Figure 1
Diagram of the study and clinical pattern at the 2-month follow-up.

References

    1. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. The International Headache Society. The International Classification of Headache Disorders, 2nd edn (ICHD-II). Cephalalgia. (2006) 26:360 10.1111/j.1468-2982.2005.00878.x
    1. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders. 2nd edition. Cephalalgia. (2004) 24:9–160. 10.1136/jnnp.2003.031286
    1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. (2013) 33:629–808. 10.1177/0333102413485658
    1. Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. (2012) 25:290–5. 10.1097/WCO.0b013e328352c431
    1. Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barrè J, Katsarava Z, et al. . The cost of headache disorders in Europe: the eurolight project. Eur J Neurol. (2012) 19:703–11. 10.1111/j.1468-1331.2011.03612.x
    1. Radat F, Sakh D, Lutz G, ElAmrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache. (1999) 39:477–80. 10.1046/j.1526-4610.1999.3907477.x
    1. Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, et al. . Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. (2005) 25:519–22. 10.1111/j.1468-2982.2005.00910.x
    1. Afari N, Ahumada SM, Wright LJ, Mostoufi S, Golnari G, Reis V, et al. . Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom Med. (2014) 76:2–11. 10.1097/PSY.0000000000000010
    1. Andrasik F, Flor H, Turk DC. An expanded view of psychological aspects in head pain: the biopsychosocial model. Neurol Sci. (2005) 26:87–91. 10.1007/s10072-005-0416-7
    1. Fuh JL, Wang SJ, Juang KD, Lu SR, Liao YC, Chen SP. Relationship between childhood physical maltreatment and migraine in adolescents. Headache. (2010) 50:761–8. 10.1111/j.1526-4610.2010.01639.x
    1. Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, et al. . Childhood maltreatment and migraine (part II). Emotional abuse as a risk for headache chronification. Headache. (2010) 50:32–42. 10.1111/j.1526-4610.2009.01557.x
    1. Peterlin BL, Ward T, Lidicker J, Levin M. A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache. (2007) 47:397–401. 10.1111/j.1526-4610.2006.00713.x
    1. Schramm SH, Moebus S, Lehmann N, Galli U, Obermann M, Bock E, et al. . The association between stress and headache: A longitudinal population- based study. Cephalalgia. (2015) 35:853–63. 10.1177/0333102414563087
    1. D'Amico D, Libro G, Prudenzano MP, Peccarisi C, Guazzelli M, Relja G, et al. Stress and chronic headache. J Headache Pain. (2000) 1:49–52. 10.1007/s101940070026
    1. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. (2003) 106:81–9. 10.1016/S0304-3959(03)00293-8
    1. Altintaş E, KarakurumGöksel B, Saritürk Ç, Taşkintuna N. Evaluation of relationship between childhood maltreatment and medication overuse headache. Nöro Psikiyatr Arş. (2015) 52:267–71. 10.5152/npa.2015.8833
    1. Viana M, Bottiroli S, Sances G, Ghiotto N, Allena M, Guaschino E, et al. . Factors associated to chronic migraine with medication overuse: a cross-sectional study. Cephalalgia. (2018) 38:2045–57. 10.1177/0333102418761047
    1. Westergaard M, Glümer C, Hansen E, Jensen R. Medication overuse, healthy lifestyle behaviours and stress in chronic headache: results from a representative population-based survey. Cephalalgia. (2016) 36:15–28. 10.1177/0333102415578430
    1. Altintaş E, Karakurum Göksel B, Taşkintuna N, Saritürk Ç. Correlation between life events and quality of life in patients with medication-overuse headache. Nöro Psikiyatri Arş. (2015) 52:233–39. 10.5152/npa.2015.8799
    1. Evers S, Jensen R. Treatment of medication overuse headache – guideline of the EFNS headache panel. Eur J Neurol. (2011) 18:1115–21. 10.1111/j.1468-1331.2011.03497.x
    1. Olesen J. Detoxification for medication overuse is the primary task. Cephalalgia. (2012) 32:420–2. 10.1177/0333102411431309
    1. Tassorelli C, Jensen R, Allena M, the COMOESTAS Consortium. Jensen R, De Icco R, et al. . A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia. (2014) 34:645–55. 10.1177/0333102414521508
    1. Hagen K, Jensen R, Bøe MG, Stovner LJ. Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain. (2010) 11:373–7. 10.1007/s10194-010-0221-4
    1. Bottiroli S, Viana M, Sances G, Ghiotto N, Guaschino E, Galli F, et al. . Psychological factors associated to failure of detoxification treatment in chronic headache associated with medication overuse. Cephalalgia. (2016) 36:1356–65. 10.1177/0333102416631960
    1. Bottiroli S, Allena M, Sances G, De Icco R, Avenali M, Fadic R, et al. . Changes in anxiety and depression symptoms associated to the outcome of MOH: a post-hoc analysis of the comoestas project. Cephalalgia. (2018) 38:646–4. 10.1177/0333102417704415
    1. Sances G, Galli F, Ghiotto N, Allena M, Guaschino E, Frustaci A, et al. Factors associated with a negative outcome of medication overuse headache – a three-year follow-up (the “Care” protocol). Cephalalgia. (2013) 33:431–43. 10.1177/0333102413477737
    1. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: The effect of a 2-month drug-free period. Neurology. (2006) 66:1894–8. 10.1212/
    1. Cargnin S, Viana M, Sances G, Bianchi M, Ghiotto N, Tassorelli C, et al. . Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache. Eur J Clin Pharmacol. (2014) 70:1195–202. 10.1007/s00228-014-1726-6
    1. Rossi P, Faroni JV, Tassorelli C, Nappi G. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain. (2013) 14:10. 10.1186/1129-2377-14-10
    1. Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, et al. . Risk factors in medication-overuse headache: a 1-year follow-up study (Care II protocol). Cephalalgia. (2010) 30:329–36. 10.1111/j.1468-2982.2009.01934.x
    1. Mazzi F, Morosini P, De Girolamo G, Lussetti M, Guaraldi GP. SCID-I CV: Italian Edition. Florence: Organizzazioni Speciali; (2000).
    1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Publishing; (1994).
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. (1983) 67:361–70. 10.1111/j.1600-0447.1983.tb09716.x
    1. Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, et al. . Detecting psychological distress in cancer patients: validity of the Italian version of the hospital anxiety and depression scale. Support Care Cancer. (1999) 7:121–7. 10.1007/s005200050241
    1. The WHO QoL Group Development of the World Health Organization WHO QoL–BREF quality of life assessment. Psychol Med. (1998) 28:551–8. 10.1017/S0033291798006667
    1. Girolamo G, Rucci P, Scocco P, Becchi A, Coppa F, D'Addario A, et al. . Quality of life assessment: validation of the Italian version of the WHOQOL-Brief. Epidemiologia e Psichiatria Sociale. (2000) 9:45–55. 10.1017/S1121189X00007740
    1. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. (2001) 56:20–8. 10.1212/WNL.56.suppl_1.S20
    1. D'amico D, Mosconi P, Genco S, Usai S, Prudenzano AMP, Grazzi L, et al. . The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia. (2001) 21:947–52. 10.1046/j.0333-1024.2001.00277.x
    1. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, et al. . Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl. (2003) 27:169–90. 10.1016/S0145-2134(02)00541-0
    1. Bottiroli S, Galli F, Viana M, Sances G, Tassorelli C. Traumatic experiences, stressful events, and alexithymia in chronic migraine with medication overuse. Front Psychol. (2018) 9:704. 10.3389/fpsyg.2018.00704
    1. Paykel ES, Prusoff BA, Uhlenhuth EH. Scaling of life events. Arch Gen Psychiatry. (1971) 25:340–7. 10.1001/archpsyc.1971.01750160052010
    1. Tietjen GE, Brandes JL, Digre KB, Baggaley S, Martin VT, Recober A, et al. History of childhood maltreatment is associated with comorbid depression in women with migraine. Neurology. (2007) 4:959–68. 10.1212/01.wnl.0000271383.60376.67
    1. Edwards VJ, Holden GW, Felitti VJ, Anda RF. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am J Psychiatry. (2003) 160:1453–60. 10.1176/appi.ajp.160.8.1453
    1. Ney PG. Does verbal abuse leave deeper scars: A study of children and parents. Can J Psychiatry. (1987) 32:371–8. 10.1177/070674378703200509
    1. Teicher MH, Samson JA, Polcari A, McGreenery CE. Sticks, stones, and hurtful words: Relative effects of various forms of childhood maltreatment. Am J Psychiatry. (2006) 163:993–1000. 10.1176/ajp.2006.163.6.993
    1. Anderberg UM, Marteinsdottir I, Theorell T, Von Knorring L. The impact of life events in female patients with fibromyalgia and in female healthy controls. Eur Psychiatry. (2000) 15:295–301. 10.1016/S0924-9338(00)00397-7
    1. Lampe A, Doering S, Rumpold G, Sölder E, Krismer M, Kantner-Rumplmair W, et al. . Chronic pain syndromes and their relation to childhood abuse and stressful life events. J Psychosom Res. (2003) 54:361–7. 10.1016/S0022-3999(02)00399-9
    1. Jones GT, Power C, Macfarlane GJ. Adverse events in childhood and chronic widespread pain in adult life: results from the 1958 British birth cohort study. Pain. (2009) 143:92–6. 10.1016/j.pain.2009.02.003
    1. Chai J, Chen P, Feng R, Liang H, Shen X, Tong G, et al. . Life events and chronic physical conditions among left-behind farmers in rural China a cross-sectional study. BMC Publ Health. (2015) 15:594. 10.1186/s12889-015-1877-0
    1. Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. (2003) 111:564–72. 10.1542/peds.111.3.564
    1. Widom CS, Marmorstein NR, White HR. Childhood victimization and illicit drug use in middle adulthood. Psychol Addict Behav. (2006) 20:394–403. 10.1037/0893-164X.20.4.394
    1. Radat F, Creac'h C, Guegan-Massardier E, Mick G, Guy N, Fabre N, et al. . Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache. (2008) 48:1026–36. 10.1111/j.1526-4610.2007.00999.x
    1. Galli F, Pozzi G, Frustaci A, Allena M, Anastasi S, Chirumbolo A, et al. . Differences in the personality profile of medication overuse headache sufferers and drug addict patients: a comparative study using MMPI-2. Headache. (2011) 51:1212–27. 10.1111/j.1526-4610.2011.01978.x
    1. Sances G, Galli F, Anastasi S, Ghiotto N, De Giorgio G, Guidetti V, et al. . Medication-overuse headache and personality: a controlled study by means of the MMPI-2. Headache. (2010) 50:198–209. 10.1111/j.1526-4610.2009.01593.x
    1. Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion regulation strategies across psychopathology: a meta-analytic review. Clin Psychol Rev. (2010) 30:217–37. 10.1016/j.cpr.2009.11.004
    1. Ricketts T, Macaskill A. Gambling as emotion management: developing a grounded theory of problem gambling. Addict Res Theory. (2003) 12:77–87. 10.1080/1606635031000062074
    1. Krystal H. Integration and Self-Healing: Affect, Trauma, Alexithymia. New York, NY: Routledge; (2015).
    1. Berking M, Margraf M, Ebert D, Wupperman P, Hofmann SG, Junghanns K. Deficits in emotion-regulation skills predict alcohol use during and after cognitive-behavioral therapy for alcohol dependence. J Consult Clin Psychol. (2011) 79:307–18. 10.1037/a0023421
    1. Gratz K, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. (2004) 26:41–54. 10.1007/s10862-008-9102-4
    1. Brodsky BS, Oquendo M, Ellis SP, Haas GL, Malone KM, Mann JJ. The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry. (2001) 158:1871–7. 10.1176/appi.ajp.158.11.1871
    1. Tietjen GE, Peterlin BL. Childhood abuse and migraine: epidemiology, sex differences, and potential mechanisms. Headache. (2011) 51:869–79. 10.1111/j.1526-4610.2011.01906.x
    1. De Bellis MD, Spratt EG, Hooper SR. Neurodevelopmental biology associated with childhood sexual abuse. J Child Sex Abuse. (2011) 20:548–87. 10.1080/10538712.2011.607753
    1. Hart H, Rubia K. Neuroimaging of child abuse: a critical review. Front Hum Neurosci. (2012) 6:52. 10.3389/fnhum.2012.00052
    1. London E, Ernst M, Grant S, Bonson K, Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex. (2000) 10:334–42. 10.1093/cercor/10.3.334
    1. Dom G, Sabbe B, Hulstijn W, Van Den Brink W. Substance use disorders and the orbitofrontal cortex. Br J Psychiatry. (2005) 187:209–20. 10.1192/bjp.187.3.209
    1. Price JL. Prefrontal cortical networks related to visceral function and mood. Ann NY Acad Sci. (1999) 877:383–96. 10.1111/j.1749-6632.1999.tb09278.x
    1. Fumal A, Laureys S, Di Clemente L. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. (2006) 129:543–50. 10.1093/brain/awh691
    1. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology. (2000) 54:308–13. 10.1212/WNL.54.2.308
    1. Vaccarino AL, Sills TL, Evans KR, Kalali AH. Prevalence and association of somatic symptoms in patients with major depressive disorder. J Affect Disord. (2008) 110:270–6. 10.1016/j.jad.2008.01.009
    1. Mosley TH, Penzien DB, Johnson CA, Brantley PJ, Wittrock DA, Andrew ME, et al. Time series analysis of stress and headache. Cephalalgia. (1991) 11:306–7. 10.1177/0333102491011S11163
    1. Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry. (2000) 6:7–11.
    1. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. (2003)163:2433–45. 10.1001/archinte.163.20.2433
    1. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R. editors Textbook of Pain. 4th ed. London: Churchill Livingstone; (1999) 309–29.
    1. De Benedictis G, Lorenzetti A. The role of stressful life events in the persistence of primary headache: major events vs. daily hassles. Pain. (1992) 51:35–42. 10.1016/0304-3959(92)90006-W
    1. Invernizzi G, Gala C, Sacchetti E. Life events and headache. Cephalalgia. (1985) 5:229–31. 10.1177/03331024850050S245
    1. Nash JM, Thebarge RW. Understanding psychological stress, its biological processes, and impact on primary headache. Headache. (2006) 46:1377–86. 10.1111/j.1526-4610.2006.00580.x
    1. Holm JE, Holroyd KA, Hursey KG, Penzien DB. The role of stress in recurrent tension headache. Headache. (1986) 26:160–7. 10.1111/j.1526-4610.1986.hed2604160.x
    1. Martin PR, Theunissen C. The role of life event stress, coping and social support in chronic headaches. Headache. (1993) 33:301–6. 10.1111/j.1526-4610.1993.hed3306301.x
    1. Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, et al. . Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. (1998)18:455–62. 10.1111/j.1468-2982.1998.1807455.x
    1. Leistad RB, Sand T, Westgaard RH, Nilsen KB, Stovner LJ. Stress-induced pain and muscle activity in patients with migraine and tension-type headache. Cephalalgia. (2006) 26:64–73. 10.1111/j.1468-2982.2005.00997.x
    1. Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. (2015) 35:6619–29. 10.1523/JNEUROSCI.0373-15.2015
    1. Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, et al. . Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci. (2012) 16:1389–1398.
    1. Galli F. Headache and anxiety/mood disorders: are we flow into a cul-de-sac? J Headache Pain. (2017) 18:6 10.1186/s10194-016-0710-1
    1. Paivio SC, Jarry JL, Chagigiorgis H, Ralston M. Efficacy of two versions of emotion-focused therapy for resolving child abuse trauma. Psychother Res. (2010) 20:353–66. 10.1080/10503300903505274

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir